Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 8

1.

Development of [F-18]fluorine-substituted Tanaproget as a progesterone receptor imaging agent for positron emission tomography.

Lee JH, Zhou HB, Dence CS, Carlson KE, Welch MJ, Katzenellenbogen JA.

Bioconjug Chem. 2010 Jun 16;21(6):1096-104. doi: 10.1021/bc1001054.

PMID:
20496889
2.

Imaging progesterone receptor in breast tumors: synthesis and receptor binding affinity of fluoroalkyl-substituted analogues of tanaproget.

Zhou HB, Lee JH, Mayne CG, Carlson KE, Katzenellenbogen JA.

J Med Chem. 2010 Apr 22;53(8):3349-60. doi: 10.1021/jm100052k.

3.

Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget.

Fensome A, Bender R, Chopra R, Cohen J, Collins MA, Hudak V, Malakian K, Lockhead S, Olland A, Svenson K, Terefenko EA, Unwalla RJ, Wilhelm JM, Wolfrom S, Zhu Y, Zhang Z, Zhang P, Winneker RC, Wrobel J.

J Med Chem. 2005 Aug 11;48(16):5092-5.

PMID:
16078826
4.

Molecular and pharmacological properties of a potent and selective novel nonsteroidal progesterone receptor agonist tanaproget.

Zhang Z, Olland AM, Zhu Y, Cohen J, Berrodin T, Chippari S, Appavu C, Li S, Wilhem J, Chopra R, Fensome A, Zhang P, Wrobel J, Unwalla RJ, Lyttle CR, Winneker RC.

J Biol Chem. 2005 Aug 5;280(31):28468-75. Epub 2005 Jun 3.

5.

Steroid hormone receptors: an update.

Beato M, Klug J.

Hum Reprod Update. 2000 May-Jun;6(3):225-36. Review.

PMID:
10874567
6.

PET in breast cancer.

Flanagan FL, Dehdashti F, Siegel BA.

Semin Nucl Med. 1998 Oct;28(4):290-302. Review.

PMID:
9800236
7.
8.

Supplemental Content

Support Center